We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva’s Novel Oral Contraceptive Keeps Up With Competitors in Trial
Teva’s Novel Oral Contraceptive Keeps Up With Competitors in Trial
November 2, 2012
Teva’s ascending-dose, extended-regimen oral contraceptive Quartette is effective at preventing pregnancy and has a comparable safety profile to other oral birth control pills, the company said.